CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.
Trine Engelbrecht HybelMaja Ølholm VaseKristina Lystlund LauridsenMarie Beck EnemarkMichael Boe MøllerCourt PedersenGitte PedersenStephen Jacques Hamilton-DutoitNiels ObelCarsten Schade LarsenFrancesco d'AmoreMaja LudvigsenPublished in: Leukemia & lymphoma (2022)